NCT02188121View on ClinicalTrials.gov

Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2021

Conditions
Serious Mental IllnessSchizophreniaSchizoaffective DisorderBipolar DisorderCardiovascular DiseaseMajor Depressive DisorderPsychosis NOS
Interventions
DRUG

Simvastatin

3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase inhibitors

DRUG

Losartan

Angiotensin II receptor antagonist

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
collaborator

Michael J. Gill Mental Health Clinic

OTHER

collaborator

Massachusetts Mental Health Center

OTHER

collaborator

Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital

UNKNOWN

collaborator

The Edinburg Center

OTHER

lead

Mclean Hospital

OTHER

NCT02188121 - Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients | Biotech Hunter | Biotech Hunter